{"id":35483,"date":"2020-01-22T10:36:05","date_gmt":"2020-01-22T09:36:05","guid":{"rendered":"https:\/\/www.aiom.it\/?p=35483"},"modified":"2020-01-22T10:36:05","modified_gmt":"2020-01-22T09:36:05","slug":"olaparib-plus-bevacizumab-as-first-line-maintenance-in-ovarian-cancer","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/olaparib-plus-bevacizumab-as-first-line-maintenance-in-ovarian-cancer\/","title":{"rendered":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer"},"content":{"rendered":"<div class=\"p\"><em>Ray-Coquard I, Pautier P, Pignata S, P\u00e9rol D, Gonz\u00e1lez-Mart\u00edn A, Berger R, Fujiwara K, Vergote I, Colombo N, M\u00e4enp\u00e4\u00e4 J, Selle F, Sehouli J, Lorusso D, Guerra Al\u00eda EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marm\u00e9 F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators <\/em><\/div>\n<p><em>The New England Journal of Medicine, 2019 Dec 19\u00a0 <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-28246\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-221x300.jpg\" alt=\"\" width=\"221\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-221x300.jpg 221w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-768x1041.jpg 768w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-756x1024.jpg 756w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-810x1098.jpg 810w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-1140x1545.jpg 1140w\" sizes=\"auto, (max-width: 221px) 100vw, 221px\" \/><\/em><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31851799\">Abstract Link<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ray-Coquard I, Pautier P, Pignata S, P\u00e9rol D, Gonz\u00e1lez-Mart\u00edn A, Berger R, Fujiwara K, Vergote I, Colombo N, M\u00e4enp\u00e4\u00e4 J, Selle F, Sehouli J, Lorusso D, Guerra Al\u00eda EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marm\u00e9 F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":33043,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[256],"class_list":["post-35483","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en","tag-carcinoma-ovarico-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/35483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=35483"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/35483\/revisions"}],"predecessor-version":[{"id":35485,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/35483\/revisions\/35485"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/33043"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=35483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=35483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=35483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}